Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Functional hyperprolactinemia].

E Drapier-Faure

    Revue Francaise De Gynecologie Et D'Obstetrique
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Treatment for hyperprolactinemia and undetectable microadenomas is similar. Bromocriptine can shrink tumors, allowing treatment cessation, though idiopathic hyperprolactinemia cure is less common.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Acne and hormonal contraceptives].

    Annales de dermatologie et de venereologie·2010
    Same author

    [New contraceptives].

    Annales de dermatologie et de venereologie·2006
    Same author

    [HRT: abandon? Menopausal hormone replacement: future].

    Gynecologie, obstetrique & fertilite·2005
    Same author

    Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.

    Climacteric : the journal of the International Menopause Society·2005
    Same author

    [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].

    Gynecologie, obstetrique & fertilite·2005
    Same author

    [There are reasons to continue hormone replacement therapy longer than 10 years].

    Gynecologie, obstetrique & fertilite·2003
    Same journal

    Endometriomas; Operative diagnosis and treatment.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Endometriomas; Pathology and anatomy.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Pelvic endometriosis.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Uterine fibroid.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Suppurative thrombophlebitis of the left utero-ovarian vein; penicillin; Surgical treatment by venous resection; healing.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    The subtotal section of the uterine body in the fibroid.

    Revue francaise de gynecologie et d'obstetrique·2010
    See all related articles

    Area of Science:

    • Endocrinology
    • Neuroendocrinology

    Background:

    • Hyperprolactinemia can stem from idiopathic causes or small pituitary adenomas.
    • Diagnostic limitations may obscure the precise cause of hyperprolactinemia.

    Purpose of the Study:

    • To outline treatment strategies for hyperprolactinemia.
    • To discuss the role of bromocriptine in managing pituitary adenomas.

    Main Methods:

    • Review of treatment protocols for hyperprolactinemia.
    • Analysis of bromocriptine's efficacy in reducing pituitary adenoma size.

    Main Results:

    • Treatment approaches are consistent for idiopathic hyperprolactinemia and undetectable microadenomas.
    • Bromocriptine demonstrates an antitumoral effect, enabling treatment discontinuation post-adenoma shrinkage.

    Related Experiment Videos

  • Complete resolution of idiopathic hyperprolactinemia is infrequently achieved.
  • Conclusions:

    • Therapeutic management for hyperprolactinemia is standardized regardless of etiology (idiopathic vs. microadenoma).
    • Bromocriptine is effective in managing pituitary adenomas, potentially allowing for treatment cessation.
    • Achieving a definitive cure for idiopathic hyperprolactinemia remains challenging.